American Century Companies’s Caribou Biosciences CRBU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$214K Hold
112,453
﹤0.01% 2695
2025
Q4
$179K Buy
112,453
+30,651
+37% +$64.3K ﹤0.01% 2718
2025
Q3
$191K Buy
+81,802
New +$154K ﹤0.01% 2701
2025
Q1
Sell
-159,822
Closed -$254K 2900
2024
Q4
$254K Buy
159,822
+13,421
+9% +$27K ﹤0.01% 2729
2024
Q3
$287K Buy
146,401
+21,372
+17% +$43.8K ﹤0.01% 2662
2024
Q2
$205K Buy
125,029
+16,530
+15% +$52.8K ﹤0.01% 2719
2024
Q1
$558K Buy
108,499
+33,367
+44% +$206K ﹤0.01% 2413
2023
Q4
$431K Buy
75,132
+37,330
+99% +$185K ﹤0.01% 2422
2023
Q3
$181K Buy
37,802
+10,374
+38% +$64.4K ﹤0.01% 2619
2023
Q2
$117K Buy
27,428
+11,742
+75% +$52.8K ﹤0.01% 2654
2023
Q1
$80.6K Buy
15,686
+2,256
+17% +$14.1K ﹤0.01% 2574
2022
Q4
$84.3K Buy
+13,430
New +$119K ﹤0.01% 2481

Other funds holding CRBU

American Century Companies's CRBU Position: Q1 2026 in Review

American Century Companies held its Caribou Biosciences (CRBU) position steady in Q1 2026 at 112,453 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #2695.

American Century Companies first reported a position in CRBU in Q4 2022 and has held it in 12 quarters since. The position peaked at $558K in Q1 2024. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • American Century Companies held 112,453 shares of Caribou Biosciences worth $214K as of Q1 2026.
  • American Century Companies left its Caribou Biosciences share count unchanged in Q1 2026.
  • Caribou Biosciences made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2695 holding.
  • American Century Companies first reported a position in Caribou Biosciences in Q4 2022 and has held it in 12 quarters since.
  • American Century Companies's Caribou Biosciences position peaked at $558K in Q1 2024.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.